Trademark: 97898055
Word
BWANTRO
Status
Pending
Status Code
730
Status Date
Wednesday, September 25, 2024
Serial Number
97898055
Mark Type
4
Filing Date
Thursday, April 20, 2023
Published for Opposition
Tuesday, February 27, 2024

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events
Jan 18, 2024
Assigned To Examiner
Apr 24, 2023
New Application Entered
Apr 28, 2023
New Application Office Supplied Data Entered
Jan 19, 2024
Approved For Pub - Principal Register
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 27, 2024
Published For Opposition
Sep 25, 2024
Sou Teas Extension Received
Sep 25, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 25, 2024
Sou Extension 1 Filed
Sep 25, 2024
Sou Extension 1 Granted
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 23, 2024
Noa E-Mailed - Sou Required From Applicant

Trademark Alertz updated from USPTO on 2030-01-24